• FirefoxInstall the new Firefox »
  •  Dow Down0.66% Nasdaq Down0.60%

    Ampio Pharmaceuticals, Inc. (AMPE)

    -NYSE MKT
    7.50 Up 0.07(0.94%) 12:08PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 77   50   50  
    Cost of Revenue -   -   -  
    Gross Profit 77   50   50  
    Operating Expenses
    Research Development26,923  16,596  6,044  
    Selling General and Administrative12,225  7,477  5,826  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (39,071) (24,024) (11,821)
    Income from Continuing Operations
    Total Other Income/Expenses Net22  (505)228  
    Earnings Before Interest And Taxes(39,049)(24,528)(11,593)
    Interest Expense -   -   -  
    Income Before Tax(39,049)(24,528)(11,593)
    Income Tax Expense -   -   -  
    Minority Interest923  520   -  
    Net Income From Continuing Ops(38,125)(24,009)(11,593)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (38,125) (24,009) (11,593)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (38,125) (24,009) (11,593)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.